Peptide Cheat Sheet: Every Compound, What It Does, and What to Know (Save This)
This guide breaks down the most commonly discussed peptides in one place like amount to take, run time, rest periods, benefits and how much actual evidence sits behind each one.
The vendor listed next to each compound is based on my own experience and what I personally recommend as the best place to start.
Here is how to read it:
Amount: how much is typically used based on research and community experience
Run time: how long most people use it for
Break: the rest period before starting again
Why take it: why people use it and what to keep in mind
Context: extra notes worth knowing before you start, including any cautions, limitations in the research or things that are commonly reported by people who have used it
1. Fat Loss and Weight Management
| Peptide Name | Amount | Run Time | Break | Why Take It | Context |
|---|---|---|---|---|---|
| Semaglutide (GLP-1) | 0.25 mg weekly injectable, increase gradually | 12–16+ weeks | No standard break in medical use | Appetite control, weight loss, blood sugar support | Strongest evidence in this whole category; GI sides common early on |
| Tirzepatide (GLP-2) | 2.5 mg weekly injectable, increase gradually | 12–16+ weeks | No standard break in medical use | Weight loss, appetite, metabolic health | Strong clinical trial data; most people tolerate GI sides fine |
| Retatrutide (GLP-3) | 1–12 mg weekly injectable escalation | 24–48+ weeks | No standard cycling model | Triple receptor agonist; significant fat loss interest | Still investigational; GI effects and elevated heart rate have been noted |
| Cagrilintide | 0.3–2.4 mg weekly injectable | 12–24 weeks | No standard break | Appetite suppression | Often discussed alone or alongside GLP-1 compounds |
| Tesamorlin | 1.28–2 mg daily injectable | 12+ weeks | Goal dependent | Visceral fat, growth hormone axis support | FDA approved dosing exists; don't mix up formulation strengths |
| AOD-9604 | 0.25–0.5 mg daily injectable | 4–12 weeks | 2–4 weeks | Fat loss focused use | FDA has flagged limited safety data on compounded versions |
| MOTS-c | 5–10 mg weekly injectable | 4–8 weeks | 2–4 weeks | Mitochondrial and metabolic support | Common in biohacking circles; still experimental |
| 5-Amino-1MQ | 25–50 mg daily oral | 4–8 weeks | 2–4 weeks | Energy, body composition, metabolic function | Not a traditional peptide; label as experimental |
2. Injury Recovery and Healing
| Peptide Name | Amount | Run Time | Break | Why Take It | Context |
|---|---|---|---|---|---|
| BPC-157 (Also in Spray form) | 0.25–0.5 mg daily injectable or nasal | 4–8 weeks | 2–4 weeks | Gut health, tendon and ligament repair, tissue recovery | One of the most talked about healing peptides; most evidence is still preclinical |
| TB-500 / Thymosin Beta-4 / bpc157 | 2–5 mg weekly injectable | 4–8 weeks | 2–4 weeks | Full body recovery, mobility, tissue repair | Human data is still limited |
| BPC-157 + TB-500 Blend | 0.25–0.5 mg each daily injectable or nasal | 4–6 weeks | 2–4 weeks | Soft tissue support, inflammation reduction | Popular recovery stack; still considered experimental |
| KPV | 0.25–1 mg daily injectable or nasal | 4–8 weeks | 2–4 weeks | Gut lining support, inflammation, skin calming | Frequently discussed for GI and inflammatory issues |
| Thymosin Alpha-1 | 1.5–3 mg 2–3x weekly injectable | 4–12 weeks | 4 weeks | Immune regulation, inflammation support | More human literature behind it than most in this category |
| LL-37 | 0.1–0.25 mg daily injectable | 2–6 weeks | 2–4 weeks | Immune and antimicrobial support | Niche research compound; treat as experimental |
3. Muscle Growth and Performance
| Peptide Name | Amount | Run Time | Break | Why Take It | Context |
|---|---|---|---|---|---|
| CJC-1295 + Ipamorelin | 0.1–0.3 mg each, 1–2x daily injectable | 8–12 weeks | 3–4 weeks | GH support, sleep quality, recovery, lean mass | One of the most widely used recovery stacks |
| CJC-1295 DAC | 1–2 mg 1–2x weekly injectable | 8–12 weeks | 3–4 weeks | Longer acting GH support | Dosing schedule is very different from the no-DAC version |
| Ipamorelin | 0.2–0.3 mg 1–2x daily injectable | 8–12 weeks | 3–4 weeks | Recovery, sleep, GH signaling | Works well solo or stacked with CJC-1295 |
| Sermorelin | 0.1–0.3 mg nightly injectable | 8–16 weeks | 3–4 weeks | GH secretagogue, sleep, recovery | Better recognized clinically than most research peptides |
| GHRP-2 | 0.1–0.3 mg 1–3x daily injectable | 6–12 weeks | 3–4 weeks | GH release, recovery, appetite effects | More aggressive profile than Ipamorelin |
| GHRP-6 | 0.1–0.3 mg 1–3x daily injectable | 6–12 weeks | 3–4 weeks | GH release, appetite stimulation | FDA has flagged glucose and cortisol concerns for compounded versions |
| Hexarelin | 0.1–0.2 mg daily injectable | 4–8 weeks | 3–4 weeks | Potent GH secretagogue | Not for beginners; advanced use only |
| IGF-1 LR3 | 0.02–0.05 mg daily injectable | 4–6 weeks | 4 weeks | Muscle growth, recovery, satellite cell activity | Higher risk category; glucose and growth signaling concerns apply |
| IGF-1 DES | 0.02–0.1 mg injectable near training or target area | 3–4 weeks | 4 weeks | Localized recovery and anabolic interest | Niche bodybuilding research use |
4. Brain, Focus and Mood
| Peptide Name | Amount | Run Time | Break | Why Take It | Context |
|---|---|---|---|---|---|
| Semax (Also in Spray form) | 0.3–1 mg daily nasal, split doses | 2–4 weeks | 1–2 weeks | Focus, cognition, brain support, mood | Widely discussed intranasally in nootropic communities |
| Selank (Also in Spray form) | 0.25–0.5 mg 1–3x daily nasal | 2–4 weeks | 1–2 weeks | Calm focus, anxiety support, mood balance | Frequently paired with Semax |
| DSIP | 0.1–0.3 mg nightly injectable | 2–6 weeks | 1–2 weeks | Sleep support and recovery | Popular anecdotally; evidence is still developing |
| Oxytocin | 16–40 IU nasal per use or 1–10 IU injectable | As needed or short blocks | As needed | Social connection, mood, intimacy | Context of use matters a lot here |
| Dihexa | 10–30 mg daily oral or 3–5 mg topical to inner wrist daily | 2–6 weeks | 2–4 weeks | Cognitive performance interest | Highly experimental; not for beginners |
5. Skin, Hair and Anti-Aging
| Peptide Name | Amount | Run Time | Break | Why Take It | Context |
|---|---|---|---|---|---|
| GHK-Cu (Also in Spray form) | 1–2 mg daily injectable or 1–5% cream topical 1–2x daily | 4–8 weeks | 2–4 weeks | Skin quality, hair, wound support | Strong cosmetic use case; most interest is here |
| Melanotan II | 0.25–1 mg daily injectable, loading then maintenance | 4–8 weeks | 2–4 weeks | Tanning, libido, appetite effects | Mole changes and pigmentation concerns are commonly reported |
| Melanotan I | 16 mg implant or 1–2 mg daily injectable | Product specific | Product specific | Pigmentation use | Keep separate from MT-II; very different evidence and context |
| SS-31 | 1–10 mg daily injectable | 4–8 weeks | 2–4 weeks | Mitochondrial protection, cellular health, anti-aging | Highly regarded in longevity research; targets mitochondrial membrane directly |
6. Immune System and Longevity
| Peptide Name | Amount | Run Time | Break | Why Take It | Context |
|---|---|---|---|---|---|
| Thymosin Alpha-1 | 1.5–3 mg 2–3x weekly injectable | 4–12 weeks | 4 weeks | Immune support, inflammation modulation | One of the more well-supported compounds in this space |
| NAD+ (Also in Spray form) | 250–1,000 mg IV or 25–100 mg daily injectable or 250–500 mg daily oral | 4–12 weeks | 2–4 weeks | Energy, cognition, mitochondrial health | Popular in wellness clinics; route and formulation matter |
| Thymalin | 5–10 mg daily injectable for 10 consecutive days | 10–20 days | 1–3 months | Immune and longevity focused use | Niche; mostly discussed in longevity circles |
| MOTS-c | 5–10 mg weekly injectable | 4–8 weeks | 2–4 weeks | Metabolic and mitochondrial support | Also fits under the metabolic category |
7. Sexual Health and Libido
| Peptide Name | Amount | Run Time | Break | Why Take It | Context |
|---|---|---|---|---|---|
| PT-141 (Also in Spray form) | 1–2 mg injectable or nasal as needed | As needed | As needed | Libido and sexual function | An approved medical product exists; nausea is a common side effect |
| Oxytocin | 16–40 IU nasal or 1–10 IU injectable | As needed | As needed | Bonding, intimacy, mood | Crossover compound; also listed under brain and mood |
| Melanotan II | 0.25–1 mg daily injectable, loading then maintenance | 4–8 weeks | 2–4 weeks | Tanning, libido, appetite effects | Also listed under skin and anti-aging |
8. Advanced and Experimental
| Peptide Name | Amount | Run Time | Break | Context |
|---|---|---|---|---|
| Dihexa | 10–30 mg daily oral or 3–5 mg topical to inner wrist daily | 2–6 weeks | 2–4 weeks | Highly experimental; approach with serious caution |
| IGF-1 LR3 | 0.02–0.05 mg daily injectable | 4–6 weeks | 4 weeks | Advanced use; glucose and growth signaling concerns |
| IGF-1 DES | 0.02–0.1 mg injectable | 3–4 weeks | 4 weeks | Niche and advanced use only |
| Hexarelin | 0.1–0.2 mg daily injectable | 4–8 weeks | 3–4 weeks | Better suited for experienced users |
| LL-37 | 0.1–0.25 mg daily injectable | 2–6 weeks | 2–4 weeks | Experimental; handle with care |
9. Popular Blends and Stacks
| Blend | Common Use | Context |
|---|---|---|
| BPC-157 + TB-500 | Injury recovery and tissue repair | Always check how much of each compound is in the blend, not just the total |
| Cagrilintide + GLP-1 | Appetite control and metabolic support | Confirm whether the listed amount refers to each ingredient or the combined total |
Important! Please Read:
Everything here is for educational purposes only. None of this is medical advice. The majority of these compounds have not been approved by the FDA for human use and several have been flagged for safety concerns including immunogenicity, blood sugar effects and limited long term data.
Know what you're buying and who you're buying it from. At the end of the day what you put in your body is your responsibility and yours alone.
Posted Aug 3, 2026, 2:04 PM UTC